🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The primary objective of this study is to assess the pharmacokinetic parame...
Status
Completed
Location
Research Site
Start Date
2013-02
Trial ID
NCT01755494
The purpose of this study is to demonstrate bioequivalence (BE) of a 5 mg s...
Status
Completed
Location
Ppd Development, Lp
Start Date
2009-11
Trial ID
NCT01192139
Treatments Being Tested
The purpose of this study is to evaluate the pharmacokinetics of Saxaglipti...
Status
Terminated
Location
Osborne Research Center
Start Date
2012-09
Trial ID
NCT01525225
The purpose of this study is to demonstrate bioequivalence (BE) of a 5 mg s...
Status
Completed
Location
PPD Development, LP
Start Date
2009-11
Trial ID
NCT01192152
Treatments Being Tested
In this integrated, Phase I study, the safety, tolerability, food effect, a...
Status
Completed
Location
Research Site
Start Date
2017-05-25
Trial ID
NCT03138356
Treatments Being Tested
To demonstrate the bioequivalence of saxagliptin and metformin in a saxagli...
Status
Completed
Location
Local Institution
Start Date
2011-06
Trial ID
NCT01365091
The purpose of this study is to determine if tablets manufactured at differ...
Status
Completed
Location
Icon Development Solutions
Start Date
2013-06
Trial ID
NCT01874080
Treatments Being Tested
The purpose of this study is to demonstrate the bioequivalence (BE) of Saxa...
Status
Withdrawn
Location
Local Institution
Start Date
2011-03
Trial ID
NCT01305551
Treatments Being Tested